In sarcoidosis trials, time also matters
- PMID: 38237993
- DOI: 10.1183/13993003.01629-2023
In sarcoidosis trials, time also matters
Conflict of interest statement
Conflict of interest: F. Jeny reports lecture honoraria from Boehringer Ingelheim, travel support from Oxyvie, and payment from Wickenstones for an online expert questionnaire, outside the submitted work. H. Nunes reports grants from Boehringer Ingelheim, Kinevant and Atyr, and advisory board participation with Boehringer Ingelheim and Janssen, outside the submitted work. D. Valeyre reports lecture honoraria from Boehringer Ingelheim and AstraZeneca, outside the submitted work.
Comment on
-
High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).Eur Respir J. 2023 Sep 9;62(3):2300198. doi: 10.1183/13993003.00198-2023. Print 2023 Sep. Eur Respir J. 2023. PMID: 37690784 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical